Immunotech Laboratories, Inc. (Immunotech), is a development-stage company. Immunotech is engaged in the medical research and development of protein-based therapeutic and diagnostic products with applications in human immunodeficiency virus/ acquired immune deficiency syndrome (HIV/AIDS). The Company’s two products include Irreversible Pepsin Fraction (IPF) and Immune Therapeutic Vaccine-1 (ITV-1). The IPF peptide molecule is used for the treatment and prevention of the HIV/AIDS indication. The Company is focused on the commercialization of its proteins for the treatment of debilitating infectious diseases. Immunotech’s other compounds in its pipeline include pediatric HIV/AIDS treatment (ITV-2), pre-natal HIV/AIDS treatment (ITV-3) and preventive HIV/AIDS Vaccine (ITV-4).